Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

ANI Pharmaceuticals Inc (NASDAQ:ANIP)

59.61
Delayed Data
As of 4:00pm ET
 -0.58 / -0.96%
Today’s Change
26.80
Today|||52-Week Range
73.54
+32.10%
Year-to-Date
Celgene (CELG) Tops Q2 Earnings & Revenues, Lifts View
12:54pm / Zacks.com - Paid Partner Content
Curis (CRIS) in Focus: Stock Adds 5.7% in Session
Jul 27 / Zacks.com - Paid Partner Content
Alexion (ALXN) Tops Q2 Earnings and Revenues (Revised)
12:05pm / Zacks.com - Paid Partner Content
Eleven Biotherapeutics (EBIO) in Focus: Stock Rises 13%
Jul 27 / Zacks.com - Paid Partner Content
Glaxo (GSK) Beats Q2 Earnings Estimates, Revenues Up Y/Y
11:40am / Zacks.com - Paid Partner Content
After GILD Earnings, Which Biomed Stock is Best Right Now?
Jul 26 / Zacks.com - Paid Partner Content
Bristol-Myers (BMY) Beats on Q2 Earnings, Lifts Outlook
11:20am / Zacks.com - Paid Partner Content
Synta (SNTA) Cuts Q2 Loss Y/Y, Madrigal Merger in Focus
Jul 22 / Zacks.com - Paid Partner Content
BioMarin Pharmaceutical (BMRN) Jumps: Stock Rises 6.6%
8:56am / Zacks.com - Paid Partner Content
AVEO Pharmaceuticals (AVEO) Catches Eye: Stock Up 10.4%
Jul 22 / Zacks.com - Paid Partner Content
Bayer (BAYRY) Beats on Q2 Earnings, Updates 2016 Outlook
8:56am / Zacks.com - Paid Partner Content
Biogen (BIIB) Stock Up on Q2 Earnings Beat, Raised Outlook
Jul 21 / Zacks.com - Paid Partner Content
Cigna (CI) to Report Q2: Will it Continue to Beat Estimates?
7:51am / Zacks.com - Paid Partner Content
Ligand Pharmaceuticals (LGND) Jumps: Stock Rises 5.5%
Jul 21 / Zacks.com - Paid Partner Content
Vertex (VRTX) Posts Narrower Q2 Loss, Revenues Fall Short
7:51am / Zacks.com - Paid Partner Content